Clincosm LogoSign in Get a demo

adenocarcinoma

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)

Terminated
Has Results
  • Non-Small Cell Lung Cancer
  • +3 more
  • Tucson, Arizona
  • +34 more
Oct 11, 2021

Lung Cancer, Adenocarcinoma, NSCLC Trial in Germany, Spain, Switzerland (Crizotinib)

Unknown status
  • Lung Cancer
  • +2 more
  • Heidelberg, Baden-Würtemberg, Germany
  • +17 more
Jul 11, 2019

Low Rectal Cancer Study (MERCURY II)

Unknown status
  • Adenocarcinoma
  • +15 more
    • Berlin, Germany
    • +16 more
    Sep 17, 2018

    NSCLC, Adenocarcinoma Trial in Worldwide (Pemetrexed, BIBW 2992, Cisplatin)

    Completed
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Adenocarcinoma
    • Fayetteville, Arkansas
    • +132 more
    Mar 9, 2018

    Carcinoma, Adenocarcinoma, Renal Cell Trial in Worldwide (RAD001(everolimus), interferon alfa-2a, bevacizumab)

    Completed
    Has Results
    • Carcinoma
    • +4 more
    • Fayetteville, Arkansas
    • +107 more
    Feb 13, 2017

    Carcinoma, Renal Cell, Non Clear Cell Renal Carcinoma Trial in Worldwide (RAD001)

    Completed
    Has Results
    • Carcinoma
    • +4 more
    • Brussels, Belgium
    • +18 more
    Jul 26, 2016

    Adenocarcinoma Trial in Germany (Sunitinib, Placebo)

    Completed
    • Adenocarcinoma
    • Mainz, Rheinland-Pfalz, Germany
    • +15 more
    May 13, 2014

    Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

    Terminated
    • Hepatocellular Carcinoma Non-resectable
    • +12 more
    • Beverly Hills, California
    • +162 more
    Sep 7, 2012